Clinical Trial Update: Study Evaluating the Safety and Efficacy of Bazedoxifene in Postmenopausal Asian Women [Phase 3]

View source ↗

Summary

Phase 3 trial evaluating the safety and efficacy of Bazedoxifene in postmenopausal Asian women has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Osteoporosis

Drugs mentioned

• Bazedoxifene (bazedoxifene)

Snippet

Sponsor: Wyeth is now a wholly owned subsidiary of Pfizer | Conditions: Postmenopause, Osteoporosis | Phase 3 | Status: COMPLETED